MEGAN MOORE: Open Payments
NPI 1811518830 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 46 payments from 14 companies in 2025. Trend: 2023 $189 · 2024 $391 · 2025 $985
Food & beverage: $868Education: $117
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 4 | $192 |
| GlaxoSmithKline, LLC. | 13 | $165 |
| Philips North America LLC | 6 | $103 |
| GENZYME CORPORATION | 3 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Insmed, Inc. | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Amgen Inc. | 2 | $44 |
| United Therapeutics Corporation | 2 | $42 |
Products named: DUPIXENT, TRELEGY ELLIPTA, Vest Therapy Und, WAKIX, Arikayce, JASCAYD, TEZSPIRE, Tyvaso.
Industry payments across AL — which companies pay providers there.
